S-1 Plus Leucovorin and Oxaliplatin vs S-1 Plus Cisplatin as First-Line Therapy in Patients With Advanced Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
S-1 Plus Leucovorin and Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Therapy in Patients With Advanced Gastric Cancer (SOLAR): A Randomised, Open-Label, Phase 3 Trial
Lancet Oncol 2020 Jul 16;[EPub Ahead of Print], YK Kang, K Chin, HC Chung, S Kadowaki, SC Oh, N Nakayama, KW Lee, H Hara, IJ Chung, M Tsuda, SH Park, H Hosaka, S Hironaka, Y Miyata, MH Ryu, H Baba, I Hyodo, YJ Bang, N BokuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.